REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreightons Regulatory News (CRL)

Share Price Information for Creightons (CRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 25.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 4.00 (17.391%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 25.00
CRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed sale of Real Shaving Company Business

30 Apr 2015 07:00

RNS Number : 7702L
Creightons PLC
29 April 2015
 

29 April 2015

 

Creightons Plc

 

Proposed disposal of ''The Real Shaving Company'' Business

 

Notice of General Meeting

Introduction

Creightons plc ("Creightons", the ''Company'' or the "Group"), a leading distributor and award winning manufacturer of personal care products and brand developer, announces that the Company and its wholly-owned subsidiary, Potter & Moore Innovations Ltd ("Potter & Moore"), have entered into a conditional Business Sale Agreement (''Agreement'') for the sale of the business and assets relating to The Real Shaving Company Business (the ''Sale'') to Swallowfield plc.

General Meeting

The Sale, because of its size in relation to the market value of the Company, is a Class 1 transaction for Creightons under the Listing Rules and is therefore conditional upon the approval of Shareholders. A General Meeting is to be held at 1210 Lincoln Road, Peterborough, PE4 6ND at 11:30 am on 27 May 2015 for the purpose of seeking Shareholders' approval.

Information on The Real Shaving Company Business

The Real Shaving Company Business being sold includes all of the business and assets of The Real Shaving Company brand ("the Brand") including the trademarks and other intellectual property associated with the Brand, the unique RSC Product formulations, the goodwill of The Real Shaving Company Business and all other rights associated with the Brand.

As at 30 September 2014, the Real Shaving Company Business had identified net and gross assets of £169,000 (given there were no liabilities), with attributable loss for the six months to 30 September 2014 of £7,000.

Consideration

The consideration for the Sale will comprise of an initial cash consideration of £900,000 payable upon completion of the Sale ("Completion"), a further cash consideration of £100,000 payable upon receipt of confirmation from two specified key retailers that The Real Shaving Company products ("RSC Products") will continue to have product representation in their physical stores, and payment for all stocks of RSC Products held at Completion which have a retail listing. The Board estimates that such stocks at Completion will be valued at approximately £170,000; but the value of the stock is subject to customary stock movements between the date of this announcement and completion of the Sale.

Effects of the Sale on the Company, and application of proceeds

Following Completion, assuming the maximum sale price is received and taking account of the £170,000 representing the estimated value of stock at Completion, net cash proceeds (after estimated taxes, transaction fees and a contractual payment to a director as set out in the paragraph below) of approximately £1,014,000 are expected to be received and a post-tax profit on the Sale of approximately £844,000 is expected to be realised.

 

In the year to 31March 2014, the Company generated revenue of £19,352,000 with gross profit of £7,892,000 and the Directors believe, on an unaudited pro forma basis, the Group, assuming the Sale at the start of the period, would have generated revenue for the year of £18,162,000 with gross profit of £7,277,000.

 

In relation to the contractual payment to a director as referred to above, William McIlroy is Executive Chairman of the Group, and his services as a director of Group companies are provided by Lesmac Securities Limited ("Lesmac") (a company of which Mr McIlroy is a director and the sole shareholder) under an agreement for services dated 16 January 2002. Under that agreement, which was approved by Shareholders on an annual basis as part of the Directors' remuneration policy at the Company's annual general meeting held on 7 August 2015, Lesmac is entitled to a Director Bonus equal to 10% of the net cash proceeds if a part of the toiletries business carried on by the Company on 16 January 2002 is sold for a price in excess of £500,000 and the net book value of the assets sold represents less than one-third of the total net asset value of the Company. In respect of the Sale, Lesmac will be entitled to a payment which the Directors estimate will be £84,000.

 

The Board intends to use the net cash proceeds first to pay off short term bank borrowings, which are expected to be approximately £275,000 at Completion.

 

The balance will initially be used for general working capital purposes and then towards business opportunities and investments as and when they arise. The Board believes that the additional working capital will allow the Group to:

 

· seek opportunities to acquire or develop other brands which the Group can develop to a level which will beattractive to potential purchasers,

· invest in developing its remaining brands, and/or

· invest in the infrastructure to enable the Remaining Group to improve performance.

 

Following the Sale, the Board considers the Group to be well positioned to take advantage of any opportunities to grow its other businesses.

 

Circular

 

A circular setting out the details of the Sale, incorporating a notice convening the General Meeting ("the Circular"), is being posted to the Company's shareholders. The Circular will shortly be made available on the Company's website www.creightons.com/investors/shareholderdocuments and will be submitted to the National Storage Mechanism.

Irrevocables

Irrevocable undertakings to vote in favour of the resolution to approve the Sale have been received by the Company from the directors of the Company in respect of their interests in 22,238,573 shares Ordinary Shares, representing approximately 37.4% of its issued ordinary share capital.

Commenting on the Sale, William McIlroy, Chairman said

''The proceeds from the sale of The Real Shaving Company business is an attractive and certain value for the Group and represents the current performance and prospects for the business. Particularly when taking into consideration the investment needed to take the brand to the next stage of its development. This sale together with the disposal of the Group's interest in the Twisted Sista brand (announced to shareholders on 27 May 2014) illustrates the significant strength the business has in brand development, which is used to the benefit of its private label and contract customers as well as adding value to the Company by creating and developing its own brands.''

The Company's final results for the year to 31 March 2015 are expected to be published by 30 June 2015.

William McIlroy

Chairman

29 April 2015

For further information please contact:

The Company Secretary:

Nicholas O'Shea, Creightons plc,1210 Lincoln Road, Peterborough, PE4 6ND, telephone +44 (0) 1733 281000.

Sponsor to the Company: Beaumont Cornish Limited, Roland Cornish or Felicity Geidt, telephone +44 (0) 20 7628 3396

 

 

 

FORWARD LOOKING STATEMENTS

This announcement contains a number of forward-looking statements relating to the Company and the Group with respect to, amongst other things, financial condition; results of operations; economic conditions in which the Company operates and in which the Company will operate; the business of the Company and the Group; future benefits of the Sale and the Company's management plans and objectives. The Company considers any statements that are not historical facts as "forward-looking statements".

 

They relate to events and trends that are subject to risks and uncertainties that could cause the actual results and financial position of either the Company or the Group to differ materially from the information presented in the relevant forward-looking statement. When used in this document the words "estimate", "project", "intend", "aim", "anticipate", "believe", "expect", "should" and similar expressions, as they relate to the Company's management, are intended to identify such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements which speak only as at the date of this document. Neither the Company, nor any member of the Group, its Directors, or Sponsor, undertake any obligation publicly to update or revise any of the forward-looking statements, whether as a result of new information, future events or otherwise, save in respect of any requirement under applicable laws, the Listing Rules, the Disclosure and Transparency Rules and other regulations.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCILMRTMBJTBRA
Date   Source Headline
15th Mar 202410:52 amRNSBlock listing Interim Review
7th Mar 20247:00 amRNSDirectorate Change
4th Dec 20237:00 amRNSHalf-year Report
27th Nov 20237:00 amRNSDirectorate Change
25th Sep 202311:50 amRNSDirector/PDMR Shareholding
15th Sep 20235:24 pmRNSBlock listing Interim Review
14th Sep 20239:52 amRNSResult of AGM
1st Sep 20235:17 pmRNSDirector/PDMR Shareholding
1st Sep 20235:05 pmRNSDirector/PDMR Shareholding
25th Aug 20233:32 pmRNSDirector/PDMR Shareholding
31st Jul 20232:53 pmRNSReplacement: Director/PDMR Shareholding
24th Jul 202311:54 amRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSAudited preliminary results
31st Mar 202310:49 amRNSTotal Voting Rights
17th Mar 20237:00 amRNSBlock listing Interim Review
16th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Jan 20232:05 pmRNSSecond Price Monitoring Extn
27th Jan 20232:00 pmRNSPrice Monitoring Extension
12th Jan 20232:05 pmRNSSecond Price Monitoring Extn
12th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Dec 202211:05 amRNSSecond Price Monitoring Extn
30th Dec 202211:00 amRNSPrice Monitoring Extension
20th Dec 20224:40 pmRNSSecond Price Monitoring Extn
20th Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20227:00 amRNSHalf-year Report
29th Nov 20224:41 pmRNSSecond Price Monitoring Extn
29th Nov 20224:36 pmRNSPrice Monitoring Extension
25th Nov 20227:00 amRNSInterim Results 2022 - announcement, presentations
27th Sep 20227:00 amRNSUpdate on Emma Hardie, Trading in own shares & TVR
20th Sep 20229:22 amRNSBlock Listing Update
24th Aug 20221:01 pmRNSResult of AGM
12th Jul 20229:05 amRNSSecond Price Monitoring Extn
12th Jul 20229:00 amRNSPrice Monitoring Extension
12th Jul 20227:00 amRNSResults for year to end 31 March 2022
11th Jul 20227:00 amRNSPreliminary Results, investor/analyst presentation
4th Jul 20224:42 pmRNSTotal Voting Rights
7th Jun 20223:28 pmRNSTotal Voting Rights
3rd May 20226:09 pmRNSTotal Voting Rights
12th Apr 20224:33 pmRNSDirector/PDMR Dealing, Total Voting Rights
21st Mar 202211:37 amRNSBlock listing Interim Review
7th Mar 20229:59 amRNSTotal Voting Rights
14th Jan 20222:58 pmRNSTotal Voting Rights
30th Dec 20217:00 amRNSHalf-year Report
15th Dec 20212:52 pmRNSNotice of Interim Results & Investors Presentation
6th Dec 20215:38 pmRNSTotal Voting Rights
25th Nov 20216:18 pmRNSDirector/PDMR Shareholding and Total Voting Rights
23rd Nov 20214:49 pmRNSDirector/PDMR Shareholding
18th Nov 202111:55 amRNSDirector/PDMR Shareholding
17th Nov 20211:58 pmRNSDirector/PDMR Shareholding
15th Nov 20217:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.